Literature DB >> 14667803

Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis.

Jonathan Richard White1, Robert A Harris, Sheena R Lee, Marie H Craigon, Katie Binley, Toby Price, Georgina L Beard, Christopher R Mundy, S Naylor.   

Abstract

The cellular response to hypoxia involves the promotion of angiogenesis, leading to increased blood flow and oxygenation. The macrophage has been identified as an orchestrator of this response in several pathologies, through the release of angiogenic factors in response to hypoxia. We have produced the first comprehensive transcriptome analysis of hypoxic primary human macrophages with respect to the regulation of angiogenesis. There is a marked induction of genes encoding factors known to stimulate angiogenesis, rather than factors that inhibit this process. We show that overexpression of the transcription factor EPAS1 using a recombinant adenoviral vector amplifies the induction of genes encoding angiogenic proteins in response to hypoxia. This defines a new strategy for enhancing transcriptome and proteome analyses by overexpressing disease-implicated genes using viral gene transfer methodologies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14667803     DOI: 10.1016/s0888-7543(03)00215-5

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  40 in total

Review 1.  Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis.

Authors:  Yuichi Oike; Kunio Yasunaga; Toshio Suda
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

2.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Authors:  Hongxia Z Imtiyaz; Emily P Williams; Michele M Hickey; Shetal A Patel; Amy C Durham; Li-Jun Yuan; Rachel Hammond; Phyllis A Gimotty; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 3.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

4.  Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.

Authors:  Fen Xu; Zhanguo Gao; Jin Zhang; Chantal A Rivera; Jun Yin; Jianping Weng; Jianping Ye
Journal:  Endocrinology       Date:  2010-03-25       Impact factor: 4.736

Review 5.  Effects of hypoxia and HIFs on cancer metabolism.

Authors:  Vera Mucaj; Jessica E S Shay; M Celeste Simon
Journal:  Int J Hematol       Date:  2012-04-27       Impact factor: 2.490

Review 6.  Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaB.

Authors:  Simon Hallam; Monica Escorcio-Correia; Robin Soper; Anne Schultheiss; Thorsten Hagemann
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

7.  Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer.

Authors:  Jessica E S Shay; Hongxia Z Imtiyaz; Sharanya Sivanand; Amy C Durham; Nicolas Skuli; Sarah Hsu; Vera Mucaj; T S Karin Eisinger-Mathason; Bryan L Krock; Dionysios N Giannoukos; M Celeste Simon
Journal:  Carcinogenesis       Date:  2014-01-09       Impact factor: 4.944

Review 8.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

Review 9.  Hypoxia-inducible factors and innate immunity in liver cancer.

Authors:  Vincent Wai-Hin Yuen; Carmen Chak-Lui Wong
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 10.  Metabolomics--a novel window into inflammatory disease.

Authors:  Martin Fitzpatrick; Stephen P Young
Journal:  Swiss Med Wkly       Date:  2013-01-21       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.